Carcinogenic and toxicologic effects of inhaled ethylene oxide and propylene oxide in F344 rats.
Public Domain
-
1984/10/01
-
Details
-
Personal Author:
-
Description:The effects of chronic inhalation exposure to ethylene-oxide (75218) and propylene-oxide (75569) were investigated in rats. Male F344- rats were exposed to 0, 50, or 100 parts per million (ppm) ethylene- oxide or 0, 100, or 300ppm propylene-oxide, 7 hours a day, 5 days a week, for 2 years. Body weights, clinical signs, hematology indices and mortality were followed. Median survival times were: controls, 720 days; ethylene-oxide exposed rats, at 50ppm, 690 days at 100ppm, 653 days; propylene-oxide exposed rats, at 100ppm, 705 days and at 300ppm, 675 days. For all propylene-oxide exposed rats, hemoglobin concentrations were significantly elevated. Rats exposed to ethylene-oxide had a higher incidence of inflammatory lesions of the lungs, nasal cavities, trachea, and internal ear. Their lungs had increased incidences of bronchiectasis, bronchial epithelial hyperplasia, and inflammations. The adrenal cortex showed vacuolation and hyperplasia. Skeletal muscle myopathy was observed in 60 percent of animals exposed to 100ppm ethylene-oxide and 33 percent of animals exposed to 300ppm propylene-oxide. Splenic extramedullary hematopoiesis was increased with both exposures of both agents. Twenty five percent of the 100ppm ethylene-oxide group developed peritoneal mesotheliomas and 6.5 percent developed brain gliomas. Pheochromocytomas were seen in 33 and 25 percent of the 100 and 300ppm propylene-oxide groups, respectively. Approximately 33 percent of all exposed animals developed pituitary adenomas. Mononuclear cell leukemia was seen in 50 percent of rats exposed to 100ppm ethylene-oxide. The authors conclude that 50ppm ethylene- oxide and 100ppm propylene-oxide exposures are toxic. Current federal permissible exposure concentrations need to be reevaluated for both substances. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0041-008X
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:69-84
-
Volume:76
-
Issue:1
-
NIOSHTIC Number:nn:00141062
-
Citation:Toxicol Appl Pharmacol 1984 Oct; 76(1):69-84
-
CAS Registry Number:
-
Federal Fiscal Year:1985
-
Peer Reviewed:True
-
Source Full Name:Toxicology and Applied Pharmacology
-
Collection(s):
-
Main Document Checksum:urn:sha-512:c69d8c131116cc3be3ec7cc3987a2d803feac5d5dfaec1e8f1b9844f585b5716e52d7b6dbb90ba3bf492186ee7d92fab840431ce01a109e580ce8367c05a3713
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like